Steve Elms has bought stock on 3 days since Mar 2021
Director at ADMA Biologics, Inc., and 1 other company
SEC CIK 0001250195 · Filings on SEC.gov ↗
Steve Elms's record
3 months after each buy, from the first price a copier could get.
2 buys have 3 months of prices so far. A record shows here at 3.
Companies
Every filing
5 filings since Mar 2021, newest first
About Steve Elms
Steven A. Elms is the Chairman of the Board of Directors at ADMA Biologics, Inc. (ADMA), a position he has held since joining the board in 2007. He also serves on the company's Governance and Nominations Committee.( As a Managing Partner at Aisling Capital since 2000, Elms brings extensive expertise in life sciences investments.(
Elms has a distinguished career in investment banking and healthcare. Previously, he was a Principal in the Life Sciences Investment Banking Group at Hambrecht & Quist (later Chase H&Q), where he participated in over 60 financing and M&A transactions, raising more than $3.3 billion in capital. Earlier roles include trading mortgage-backed securities at Donaldson, Lufkin & Jenrette, pharmaceutical sales at Marion Laboratories, and consulting at The Wilkerson Group.( He currently serves on the boards of Elevation Oncology (Nasdaq: ELEV), Marker Therapeutics (Nasdaq: MRKR), and Treeline Biosciences, with past roles at Zosano Pharma and LOXO Oncology.( Elms holds a B.A. in Human Biology from Stanford University and an M.B.A. from Northwestern University's Kellogg Graduate School of Management.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.